Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119260) titled 'Clinical Study on Constructing a Machine Learning-Based Individualized Prediction Model Using Immune Response Patterns to Enhance Inhibitor Eradication Capability in Pediatric Hemophilia A' on Feb. 25.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Beijing Childrens Hospital,Capital Medical University
Condition:
Hemophilia A
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-01
Target Sample Size: Treatment regimen guided by the "Individualized Prediction Model":57;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.c...